{"id":239518,"date":"2024-10-19T15:40:06","date_gmt":"2024-10-19T15:40:06","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iec-630092019\/"},"modified":"2024-10-25T10:22:27","modified_gmt":"2024-10-25T10:22:27","slug":"bs-en-iec-630092019","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iec-630092019\/","title":{"rendered":"BS EN IEC 63009:2019"},"content":{"rendered":"
IEC 63009:2019 is applicable to ultrasonic equipment designed for physiotherapy containing an ultrasonic transducer generating ultrasound in the frequency range 20 kHz to 500 kHz. This document only relates to ultrasonic physiotherapy equipment employing a single plane non-focusing circular transducer per treatment head, producing static beams perpendicular to the face of the treatment head. This document specifies: \u2022 methods of measurement and characterization of the output of ultrasonic physiotherapy equipment based on reference testing methods; \u2022 characteristics to be specified by manufacturers of ultrasonic physiotherapy equipment; \u2022 methods of measurement and characterization of the output of ultrasonic physiotherapy equipment based on routine testing methods; \u2022 acceptance criteria for aspects of the output of ultrasonic physiotherapy equipment. The therapeutic value and methods of use of ultrasonic physiotherapy equipment are not within the scope of this document. Excluded equipment includes, but is not limited to: \u2022 equipment in which ultrasound waves are intended to destroy conglomerates (for example stones in the kidneys or the bladder) or tissue of any type; \u2022 equipment in which a tool is driven by ultrasound (for example surgical scalpels, phacoemulsifiers, dental scalers or intracorporeal lithotripters); \u2022 equipment in which ultrasound waves are intended to sensitize tissue to further therapies (for example radiation or chemotherapy); \u2022 equipment in which ultrasound waves are intended to treat cancerous (i.e., malignant) or pre-cancerous tissue, or benign masses, such as High Intensity Focused Ultrasound (HIFU) or High Intensity Therapeutic Ultrasound (HITU).<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Annex ZA(normative)Normative references to international publicationswith their corresponding European publications <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | English CONTENTS <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | FOREWORD <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | INTRODUCTION <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 4 Symbols <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 5 Ultrasonic field specifications <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 6 Conditions of measurement and test equipment used for field measurements 6.1 General <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 6.2 Test vessel 6.3 Hydrophone 6.4 RMS or peak signal measurement <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 7 Type testing reference procedures and measurements 7.1 General 7.2 Rated output power 7.3 Hydrophone measurements <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 7.4 Effective radiating area <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 7.5 Reference type testing parameters <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 7.6 Acceptance criteria for reference type testing 8 Routine measurement procedure 8.1 General 8.2 Rated output power <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 8.3 Effective radiating area 8.4 Beam non-uniformity ratio 8.5 Effective intensity 8.6 Acceptance criteria for routine testing <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 9 Sampling and uncertainty determination 9.1 Reference type testing measurements 9.2 Routine measurements 9.3 Uncertainty determination <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | Annex\u00a0A (informative) Guidance for performance and safety A.1 General A.2 Rated output power A.3 Effective intensity A.4 Beam non-uniformity ratio A.4.1 General A.4.2 Rationale behind using a limiting value for the beam non-uniformity ratio, RBN <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | Annex\u00a0B (normative)Raster scan measurement and analysis procedures B.1 General B.2 Requirements for raster scans B.3 Requirements for analysis of raster scan data B.3.1 General <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | B.3.2 Total mean square acoustic pressure B.3.3 Calculation of the beam cross-sectional area, ABCS <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | Annex\u00a0C (normative)Diametrical (line) scan measurement and analysis procedures C.1 General C.2 Requirements for line scans C.3 Analysis of line scans <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Table\u00a0C.1 \u2013 Constitution of the transformed array [B] used for the analysis of half-line scans <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Ultrasonics. Physiotherapy systems. Field specifications and methods of measurement in the frequency range 20 kHz to 500 kHz<\/b><\/p>\n |